159 related articles for article (PubMed ID: 19717725)
1. Human pharmacokinetics/pharmacodynamics of an interleukin-4 and interleukin-13 dual antagonist in asthma.
Burmeister Getz E; Fisher DM; Fuller R
J Clin Pharmacol; 2009 Sep; 49(9):1025-36. PubMed ID: 19717725
[TBL] [Abstract][Full Text] [Related]
2. Inhaled vs subcutaneous effects of a dual IL-4/IL-13 antagonist in a monkey model of asthma.
Tomkinson A; Tepper J; Morton M; Bowden A; Stevens L; Harris P; Lindell D; Fitch N; Gundel R; Getz EB
Allergy; 2010 Jan; 65(1):69-77. PubMed ID: 19796211
[TBL] [Abstract][Full Text] [Related]
3. Pitrakinra for asthma.
Antoniu SA; Cojocaru I
Expert Opin Biol Ther; 2010 Nov; 10(11):1609-15. PubMed ID: 20923253
[TBL] [Abstract][Full Text] [Related]
4. Population pharmacokinetic model of human insulin following different routes of administration.
Potocka E; Baughman RA; Derendorf H
J Clin Pharmacol; 2011 Jul; 51(7):1015-24. PubMed ID: 20940337
[TBL] [Abstract][Full Text] [Related]
5. Preclinical safety and pharmacology of an anti-human interleukin-13 monoclonal antibody in normal macaques and in macaques with allergic asthma.
Martin PL; Fisher D; Glass W; O'Neil K; Das A; Martin EC; Li L
Int J Toxicol; 2008; 27(5):351-8. PubMed ID: 19037805
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic/pharmacodynamic evaluation of inhalation drugs: application to targeted pulmonary delivery systems.
Tayab ZR; Hochhaus G
Expert Opin Drug Deliv; 2005 May; 2(3):519-32. PubMed ID: 16296772
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacokinetics and pharmacodynamics of proxyphylline in asthmatic children].
Kalla M; Richter O; Reinhardt D
Monatsschr Kinderheilkd; 1985 Aug; 133(8):520-6. PubMed ID: 4047067
[TBL] [Abstract][Full Text] [Related]
8. Mometasone furoate: an inhaled glucocorticoid for the management of asthma in adults and children.
Cowie RL; Giembycz MA; Leigh R
Expert Opin Pharmacother; 2009 Aug; 10(12):2009-14. PubMed ID: 19618993
[TBL] [Abstract][Full Text] [Related]
9. Pitrakinra, a dual IL-4/IL-13 antagonist for the potential treatment of asthma and eczema.
Antoniu SA
Curr Opin Investig Drugs; 2010 Nov; 11(11):1286-94. PubMed ID: 21157648
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the administration time effect on the cumulative cortisol suppression and cumulative lymphocytes suppression for once-daily inhaled corticosteroids: a population modeling/simulation approach.
Wu K; Goyal N; Stark JG; Hochhaus G
J Clin Pharmacol; 2008 Sep; 48(9):1069-80. PubMed ID: 18728243
[TBL] [Abstract][Full Text] [Related]
11. Anti-IL-4/-13 based therapy in asthma.
Walsh GM
Expert Opin Emerg Drugs; 2015 Sep; 20(3):349-52. PubMed ID: 26021492
[TBL] [Abstract][Full Text] [Related]
12. Population Pharmacokinetic Modeling of Benralizumab in Adult and Adolescent Patients with Asthma.
Yan L; Wang B; Chia YL; Roskos LK
Clin Pharmacokinet; 2019 Jul; 58(7):943-958. PubMed ID: 30854591
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of the Inhaled Selective Glucocorticoid Receptor Modulator AZD5423 Following Inhalation Using Different Devices.
Melin J; Prothon S; Kloft C; Cleton A; Amilon C; Jorup C; Bäckman P; Olsson B; Hamrén UW
AAPS J; 2017 May; 19(3):865-874. PubMed ID: 28281196
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and anti-asthmatic potential of non-parenterally administered recombinant human interleukin-1 receptor antagonist in animal models.
Li T; Lu WL; Hong HY; Yao YS; Han P; Li ZK; Wang GL; Cao Y; Liu XR; Wang JC; Zhang X; Zhang Q
J Pharmacol Sci; 2006 Nov; 102(3):321-30. PubMed ID: 17116976
[TBL] [Abstract][Full Text] [Related]
15. Technology evaluation: EPI-2010, EpiGenesis.
Zhang Z
Curr Opin Mol Ther; 2002 Jun; 4(3):275-80. PubMed ID: 12139314
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary delivery of TH9507, a growth hormone releasing factor analogue, in the dog.
Jansen M; Darby I; Abribat T; Dubreuil P; Ferdinandi ES; Hardy JG
Int J Pharm; 2004 May; 276(1-2):75-81. PubMed ID: 15113616
[TBL] [Abstract][Full Text] [Related]
17. Population Pharmacokinetics and Pharmacodynamics of Benralizumab in Healthy Volunteers and Patients With Asthma.
Wang B; Yan L; Yao Z; Roskos LK
CPT Pharmacometrics Syst Pharmacol; 2017 Apr; 6(4):249-257. PubMed ID: 28109128
[TBL] [Abstract][Full Text] [Related]
18. Rapid absorption of sumatriptan powder and effects on glyceryl trinitrate model of headache following intranasal delivery using a novel bi-directional device.
Luthringer R; Djupesland PG; Sheldrake CD; Flint A; Boeijinga P; Danjou P; Demazières A; Hewson G
J Pharm Pharmacol; 2009 Sep; 61(9):1219-28. PubMed ID: 19703372
[TBL] [Abstract][Full Text] [Related]
19. Inhaling medicines: delivering drugs to the body through the lungs.
Patton JS; Byron PR
Nat Rev Drug Discov; 2007 Jan; 6(1):67-74. PubMed ID: 17195033
[TBL] [Abstract][Full Text] [Related]
20. Omalizumab: overview of pharmacology and efficacy in asthma.
Ledford DK
Expert Opin Biol Ther; 2009 Jul; 9(7):933-43. PubMed ID: 19527111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
